2016 annual financial data

Galectin Therapeutics 2016 Net margin

Galectin Therapeutics 2016 net margin with verified reported values.

Direct answer

Net margin was Not calculable.

Operating income was -21,481,000 USD and net income was -21,436,000 USD.
Operating cash flow was -16,409,000 USD.

Get free Galectin Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-21,481,000 USD
Net income
-21,436,000 USD
Operating cash flow
-16,409,000 USD